CGEM
Price
$7.67
Change
-$0.49 (-6.00%)
Updated
Jun 20 closing price
Capitalization
452.64M
46 days until earnings call
XOMA
Price
$24.05
Change
-$0.57 (-2.32%)
Updated
Jun 20 closing price
Capitalization
287.92M
45 days until earnings call
Interact to see
Advertisement

CGEM vs XOMA

Header iconCGEM vs XOMA Comparison
Open Charts CGEM vs XOMABanner chart's image
Cullinan Therapeutics
Price$7.67
Change-$0.49 (-6.00%)
Volume$663K
Capitalization452.64M
XOMA Royalty
Price$24.05
Change-$0.57 (-2.32%)
Volume$142.23K
Capitalization287.92M
CGEM vs XOMA Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. XOMA commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Hold and XOMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (CGEM: $7.67 vs. XOMA: $24.05)
Brand notoriety: CGEM and XOMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 162% vs. XOMA: 349%
Market capitalization -- CGEM: $452.64M vs. XOMA: $287.92M
CGEM [@Biotechnology] is valued at $452.64M. XOMA’s [@Biotechnology] market capitalization is $287.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.21B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileXOMA’s FA Score has 1 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • XOMA’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than XOMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 5 TA indicator(s) are bullish while XOMA’s TA Score has 3 bullish TA indicator(s).

  • CGEM’s TA Score: 5 bullish, 5 bearish.
  • XOMA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than XOMA.

Price Growth

CGEM (@Biotechnology) experienced а -10.92% price change this week, while XOMA (@Biotechnology) price change was +0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

CGEM is expected to report earnings on Aug 07, 2025.

XOMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($453M) has a higher market cap than XOMA($288M). XOMA YTD gains are higher at: -8.486 vs. CGEM (-37.028). XOMA has higher annual earnings (EBITDA): 6M vs. CGEM (-208.62M). CGEM has more cash in the bank: 304M vs. XOMA (92.6M). CGEM has less debt than XOMA: CGEM (1.84M) vs XOMA (114M). XOMA has higher revenues than CGEM: XOMA (13M) vs CGEM (0).
CGEMXOMACGEM / XOMA
Capitalization453M288M157%
EBITDA-208.62M6M-3,477%
Gain YTD-37.028-8.486436%
P/E RatioN/AN/A-
Revenue013M-
Total Cash304M92.6M328%
Total Debt1.84M114M2%
FUNDAMENTALS RATINGS
XOMA: Fundamental Ratings
XOMA
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMXOMA
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 19 days ago
73%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNLVX19.960.02
+0.10%
Dunham Large Cap Value N
MRGRX55.33-0.13
-0.23%
MFS Core Equity I
INSCX21.19-0.09
-0.42%
Catalyst Insider Buying C
BIECX24.13-0.17
-0.70%
Brandes International Equity C
GFFDX83.00-0.95
-1.13%
Invesco Global Focus R5

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEM jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-6.00%
MDGL - CGEM
50%
Loosely correlated
+1.10%
DNLI - CGEM
47%
Loosely correlated
-1.42%
FATE - CGEM
46%
Loosely correlated
-1.65%
BEAM - CGEM
46%
Loosely correlated
-1.35%
IDYA - CGEM
45%
Loosely correlated
-0.87%
More